We are live on ! Find out more

1,601 hedge funds and large institutions have $95.7B invested in Amgen in 2017 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 680 increasing their positions, 577 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 151 | Existing positions closed: 71

22% more funds holding in top 10

Funds holding in top 10: 6579 (+14)

18% more repeat investments, than reductions

Existing positions increased: 680 | Existing positions reduced: 577

13% more capital invested

Capital invested by funds: $85.1B → $95.7B (+$10.7B)

4% more funds holding

Funds holding: 1,5421,601 (+59)

1.05% more ownership

Funds ownership: 78.1%79.15% (+1.1%)

33% less call options, than puts

Call options by funds: $1.14B | Put options by funds: $1.7B

Holders
1,601
Holders Change
+59
Holders Change %
+3.83%
% of All Funds
39.85%
Holding in Top 10
79
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+21.54%
% of All Funds
1.97%
New
151
Increased
680
Reduced
577
Closed
71
Calls
$1.14B
Puts
$1.7B
Net Calls
-$562M
Net Calls Change
-$95.5M
Name Holding Trade Value Shares
Change
Change in
Stake
AAC
501
Asset Advisors Corp
Georgia
$6.11M +$261K +1,571 +4%
SM
502
Sabby Management
Florida
$6.09M -$35.8M -215,691 -85%
QT
503
Quantbot Technologies
New York
$6.08M +$5.43M +32,684 +742%
QIM
504
Quest Investment Management
Oregon
$6.01M -$3.77M -22,713 -38%
GC
505
Gratus Capital
Georgia
$6M -$2.48M -14,931 -29%
BAAM
506
Baker Avenue Asset Management
California
$5.95M +$390K +2,350 +7%
ACP
507
Ashfield Capital Partners
California
$5.93M -$1.41M -8,465 -19%
Capstone Investment Advisors
508
Capstone Investment Advisors
New York
$5.9M +$5.08M +30,591 +567%
CAM
509
Congress Asset Management
Massachusetts
$5.89M +$105K +634 +2%
Capital Fund Management (CFM)
510
Capital Fund Management (CFM)
France
$5.87M +$2M +12,009 +50%
OIM
511
Opus Investment Management
Massachusetts
$5.84M +$332K +2,000 +6%
LG
512
Leuthold Group
Minnesota
$5.76M -$130K -783 -2%
Fayez Sarofim & Co
513
Fayez Sarofim & Co
Texas
$5.75M -$4.37M -26,305 -43%
JFGIW
514
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$5.74M +$396K +2,386 +7%
CIP
515
Convergence Investment Partners
Florida
$5.71M -$331K -1,990 -5%
DHFB
516
Dixon Hubard Feinour & Brown
Virginia
$5.7M -$4.15K -25 -0.1%
NA
517
Neuburgh Advisers
California
$5.68M +$1.05M +6,336 +22%
UCFA
518
United Capital Financial Advisors
Texas
$5.67M -$479K -2,880 -8%
SGA
519
Strategic Global Advisors
California
$5.64M -$1.02M -6,129 -15%
GP
520
Girard Partners
Pennsylvania
$5.64M +$1.09M +6,569 +24%
EWM
521
Endurance Wealth Management
Rhode Island
$5.62M
RJA
522
Robshaw & Julian Associates
New York
$5.61M -$831 -5 -0%
TCOV
523
Trust Company of Vermont
Vermont
$5.54M +$268K +1,614 +5%
Connor, Clark & Lunn Investment Management (CC&L)
524
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$5.53M -$8.7M -52,350 -61%
WT
525
Whittier Trust
California
$5.52M +$116K +700 +2%

AMGN Hedge Fund Activity: Q1 2017 in Review

1,601 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2017, worth a combined $95.7B — up 13% from $85.1B a quarter earlier.

Buyers outnumbered sellers: 151 funds opened new AMGN positions and 71 closed out — a net gain of 80 holders — while 680 added to existing stakes and 577 trimmed.

The largest buyer was BlackRock, adding an estimated $7.72B. The largest seller was Capital Research Global Investors, cutting an estimated $1.36B.

  • 1,601 institutional investors held Amgen (AMGN) as of Q1 2017, up from 1,542 in Q4 2016.
  • Funds reported $95.7B of Amgen stock for Q1 2017, up 13% quarter-over-quarter.
  • 151 funds opened new Amgen positions in Q1 2017 and 71 closed out, a net change of +80 holders.
  • The largest Amgen buyer in Q1 2017 was BlackRock, an estimated $7.72B added.
  • The largest Amgen seller in Q1 2017 was Capital Research Global Investors, an estimated $1.36B sold.

Based on aggregated 13F filings for Q1 2017.